(Reuters) -U.S. President Donald Trump will sign an executive order on Monday to streamline regulations surrounding pharmaceutical manufacturing in the United States, the Washington Post reported, citing two White House officials.

The executive order adds on to Trump’s planned tariffs on pharmaceuticals in his overall strategy to onshore production of medicines. At the White House event, Trump told reporters that he will announce pharmaceutical-specific tariffs in the next two weeks.

The president signed an executive order to promote domestic pharma production Monday, and said that news on drug tariffs will come within two weeks.